Clients by Specialty

 

The projects awarded to Rx-Press encompass many diseases states and medical disciplines.

Therapeutic areas include:

—   Psychiatry – CME newsletters for New York University Attention Deficit Hyperactivity Disorder Program funded by Shire Pharmaceuticals (Adderall XR, Intuiv, Vyvanse); PowerPoint presentations for Bristol-Myers Squibb (Abilify); co-authored article for American Psychiatric News on adult ADHD, funded by McNeil Pediatrics (Concerta); pharmacokinetic and preclinical articles as well as posters for Shire (Intuiv); compiling and maintaining online London-based drug database for PsychiatryMatters.md sponsored by Organon NV (Provigil); phase 2 and phase 3 manuscripts for Pfizer (Geodon); discussion guides for roundtables and PowerPoint presentations for Jazz Pharmaceuticals (Xyrem); training manuals and monographs for Reckitt Benckiser Pharmaceuticals (Suboxone).

—   Oncology – Newsletter series on solid tumors and targeted therapies including anti-angiogenic therapy and tyrosine kinase inhibitors for Genentech (Avastin, Herceptin, Tarceva, Xeloda); book chapter on colorectal cancer for Physician’s Desk Reference; review articles on treatment of malignant gliomas, metastatic melanoma, pancreatic carcinomas, lymphomas, as well as patient’s website guide to brain tumors for Schering (Temodar); articles on aromatase inactivators for Pfizer (Aromasin).

—   Infectious disease – Web-based case studies on HIV-related topics for Boehringer Ingelheim (Viramune); PowerPoint presentations for Bristol-Myers Squibb (Reyataz); journal manuscripts on upper and lower respiratory tract infections, urinary tract infections manuscripts for Bristol-Myers Squibb (Kefzol); manuscripts on intra-abdominal infections and appendicitis for Schering-Plough (Avelox); monographs and slide presentations involving drug efficacy and hepatitis B treatment strategies for Gilead Sciences (Hepsera); efficacy and review manuscripts on the use of peg-interferon in hepatitis B for Schering-Plough (PegIntron); training manuals on treating hepatitis C for Schering-Plough (PegIntron; Intron); PowerPoint presentations for Bristol-Myers Squibb (Sustiva); 5-article CME supplement on protease inhibitors and HIV for Bristol-Myers Squibb (Reyataz); newsletter series on human papillomavirus and vaccination for Glaxo (Ceravix); physician guidelines for the use of tetanus toxoid, reduced diphtheria toxoid and acellular pertussis vaccine for Sanofi Pasteur (Adacel); manuscript on Rotavirus gastroenteritis vaccine for Merck (RotaTeq).

—   Joint and bone – Book chapter on rheumatoid arthritis for Physician’s Desk Reference; manuscripts on bisphosphonates and managing bone loss and metastases associated with cancer treatment for Amgen (Prolia); PowerPoint presentations on viscosupplementation and osteoarthritis for the knee for Genzyme (Synvisc); osteoporosis newsletter series for Sanofi-Aventis (Actonel).

—   Metabolic and cardiovascular – Journal articles on metabolic syndrome, endocannabinoid system, beta cell health, and the cultural and psychological impact of diabetes for Diabetes, a journal published by Excerpta Medica; physician’s fact pack cards for Amylin (Byetta); newsletter series on secondary stroke and manuscripts on RAAS blockade with ACE/ARB combination for Boehringer Ingelheim (Aggrenox, Micardis); articles on intravenous eptifibatide in patients undergoing coronary artery bypass grafting for Millennium Pharmaceutics (Integrilin).

—   Other therapeutic areas – Pain management, migraine, psoriasis, ophthalmology, asthma, gynecology and obstetrics, epilepsy and seizure disorders, sleep disorders (Lunesta), erectile dysfunction (Cialis, Viagra), interleukins, and herbal and alternative medicine.